|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-1.20/-1.91
|
企业价值
1.11B
|
资产负债 |
每股账面净值
0.42
|
现金流量 |
现金流量率
--
|
损益表 |
收益
1.70M
|
每股收益
0.02
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/02 14:20 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3,AUTO5, AUTO6, AUTO7 & AUTO8. |